Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hernandez

Showing results (201-210 of 210) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 210 results.
Nature Communications|June 3, 2020
Integrating whole-genome sequencing within the National Antimicrobial Resistance Surveillance Program in the PhilippinesSilvia Argimón, Melissa A L Masim, June M Gayeta, et al.
BMJ Open|November 23, 2022
Investigating transmission of SARS-CoV-2 using novel face mask sampling: a protocol for an observational prospective study of index cases and their contacts in a congregate settingThomas Jaenisch, Molly M Lamb, Emily N Gallichotte, et al.
Blood|April 28, 2016
Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patientsBruno Paiva, Maria-Teresa Cedena, Noemi Puig, et al.
Blood Cancer Journal|April 29, 2024
The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progressionA Medina-Herrera, I Vazquez, I Cuenca, et al.
Leukemia|August 2, 2016
Differentiation stage of myeloma plasma cells: biological and clinical significanceB Paiva, N Puig, M T Cedena, et al.
Blood|April 17, 2020
Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myelomaCatarina Maia, Noemi Puig, Maria-Teresa Cedena, et al.
Blood|June 11, 2025
High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 GEM trialJuan-Jose Lahuerta, Jesús F San-Miguel, Ana Jiménez-Ubieto, et al.
Nature Communications|September 20, 2023
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistanceCirino Botta, Cristina Perez, Marta Larrayoz, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Are myeloma patients with renal failure candidates for autologous stem cell transplantation?J F San Miguel, J J Lahuerta, R García-Sanz, et al.
Environmental Research|January 10, 2026
Traffic-related air pollution in utero modifies cytokine responses to stimuli of umbilical cord blood cells: a cohort studyAzahara M García-Serna, Elena Martín-Orozco, Pedro Jiménez-Guerrero, et al.
Pageof 21

Showing results (201-210 of 210) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 210 results.
Nature Communications|June 3, 2020
Integrating whole-genome sequencing within the National Antimicrobial Resistance Surveillance Program in the PhilippinesSilvia Argimón, Melissa A L Masim, June M Gayeta, et al.
BMJ Open|November 23, 2022
Investigating transmission of SARS-CoV-2 using novel face mask sampling: a protocol for an observational prospective study of index cases and their contacts in a congregate settingThomas Jaenisch, Molly M Lamb, Emily N Gallichotte, et al.
Blood|April 28, 2016
Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patientsBruno Paiva, Maria-Teresa Cedena, Noemi Puig, et al.
Blood Cancer Journal|April 29, 2024
The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progressionA Medina-Herrera, I Vazquez, I Cuenca, et al.
Leukemia|August 2, 2016
Differentiation stage of myeloma plasma cells: biological and clinical significanceB Paiva, N Puig, M T Cedena, et al.
Blood|April 17, 2020
Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myelomaCatarina Maia, Noemi Puig, Maria-Teresa Cedena, et al.
Blood|June 11, 2025
High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 GEM trialJuan-Jose Lahuerta, Jesús F San-Miguel, Ana Jiménez-Ubieto, et al.
Nature Communications|September 20, 2023
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistanceCirino Botta, Cristina Perez, Marta Larrayoz, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Are myeloma patients with renal failure candidates for autologous stem cell transplantation?J F San Miguel, J J Lahuerta, R García-Sanz, et al.
Environmental Research|January 10, 2026
Traffic-related air pollution in utero modifies cytokine responses to stimuli of umbilical cord blood cells: a cohort studyAzahara M García-Serna, Elena Martín-Orozco, Pedro Jiménez-Guerrero, et al.
Pageof 21